These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 28614452)

  • 1. [Profile of clinical trials enrolling Brazilian children].
    Vieira JML; Lima EDC; Land MGP; Ventura M; Coelho HLL
    Cad Saude Publica; 2017 Jun; 33(5):e00169515. PubMed ID: 28614452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of drug preparations for use in children in Brazil.
    Costa PQ; Rey LC; Coelho HL
    J Pediatr (Rio J); 2009; 85(3):229-35. PubMed ID: 19452078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brazilian Clinical Trials Registry and the challenges for clinical research governance.
    Laguardia J; Piolli AL; Prevot M; Ramalho L; Gamarski R; Nishizawa C
    J Evid Based Med; 2011; 4(3):156-60. PubMed ID: 23672720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population.
    Venables R; Batchelor H; Hodson J; Stirling H; Marriott J
    Int J Pharm; 2015 Mar; 480(1-2):55-62. PubMed ID: 25601436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Access to medicines in the public sector: analysis of users of the Brazilian Unified National Health System].
    Boing AC; Bertoldi AD; Boing AF; Bastos JL; Peres KG
    Cad Saude Publica; 2013 Apr; 29(4):691-701. PubMed ID: 23568299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives.
    Dutra RC; Campos MM; Santos AR; Calixto JB
    Pharmacol Res; 2016 Oct; 112():4-29. PubMed ID: 26812486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inappropriate oral formulations and information in paediatric trials.
    Pandit S; Shah U; Kirby DJ; Nunn T; Tuleu C
    Arch Dis Child; 2010 Sep; 95(9):754-6. PubMed ID: 20605870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Priorities of clinical drug trials in Brazil and neglected diseases of poverty].
    Santana RS; Leite SN
    Rev Panam Salud Publica; 2016 Nov; 40(5):356-362. PubMed ID: 28076585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domestic violence against children and adolescents: prevalence of physical injuries in a southern Brazilian metropolis.
    Valente LA; Dalledone M; Pizzatto E; Zaiter W; de Souza JF; Losso EM
    Braz Dent J; 2015; 26(1):55-60. PubMed ID: 25672385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer incidence among children and adolescents in Brazil: first report of 14 population-based cancer registries.
    de Camargo B; de Oliveira Santos M; Rebelo MS; de Souza Reis R; Ferman S; Noronha CP; Pombo-de-Oliveira MS
    Int J Cancer; 2010 Feb; 126(3):715-20. PubMed ID: 19642142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home enteral nutrition in children: a one-year experience with 184 patients in Distrito Federal, Brazil.
    Salomon Zaban AL; Garbi Novaes MR
    Exp Biol Med (Maywood); 2010 May; 235(5):584-9. PubMed ID: 20463298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor formulation information in published pediatric drug trials.
    Standing JF; Khaki ZF; Wong IC
    Pediatrics; 2005 Oct; 116(4):e559-62. PubMed ID: 16199684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of new drugs registered in Brazil in view of the Unified Health System and the disease burden.
    Botelho SF; Martins MAP; Reis AMM
    Cien Saude Colet; 2018 Jan; 23(1):215-228. PubMed ID: 29267825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological profile of exogenous poisoning in children and adolescents from a municipality in the state of Mato Grosso].
    Oliveira FF; Suchara EA
    Rev Paul Pediatr; 2014 Dec; 32(4):299-305. PubMed ID: 25510992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
    Rose K
    Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation programs for pediatric drug research--do children really benefit?
    Boots I; Sukhai RN; Klein RH; Holl RA; Wit JM; Cohen AF; Burggraaf J
    Eur J Pediatr; 2007 Aug; 166(8):849-55. PubMed ID: 17225950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric clinical trial experience: government, child, parent and physician's perspective.
    Salazar JC
    Pediatr Infect Dis J; 2003 Dec; 22(12):1124-7. PubMed ID: 14688585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.